Recent Developments in Pharmacotherapy of Depression: Bench to Bedside

Recent Developments in Pharmacotherapy of Depression: Bench to Bedside

For the last 70 years, we did not move beyond the monoamine hypothesis of depression until the approval of the S-enantiomer of ketamine, an N-methyl-D-aspartate (NMDA) receptor blocker and the first non-monoaminergic antidepressant characterized by rapid antidepressant and antisuicidal effects. A si...

Full description

Bibliographic Details
Main Author: Mujeeb U. Shad
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Personalized Medicine
Subjects:
developments
pharmacotherapy
depression
bench
bedside
Online Access:https://www.mdpi.com/2075-4426/13/5/773

Internet

https://www.mdpi.com/2075-4426/13/5/773

Similar Items